LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • February 25th, 2021 • Clovis Oncology, Inc. • Pharmaceutical preparations
THIS LICENSE AND COLLABORATION AGREEMENT (the “Agreement”) is made and entered into as of 20 September, 2019 (the “Effective Date”) by and between 3B PHARMACEUTICALS GmbH, a limited liability company organized and existing under the laws of Germany, with registered offices at Magnusstraße 11, D-12489 Berlin, Germany (“3BP”) and CLOVIS ONCOLOGY, INC., a corporation organized and existing under the laws of the State of Delaware, USA, having offices at 5500 Flatiron Parkway, Suite 100, Boulder, Colorado 80301 USA (“Clovis”). 3BP and Clovis are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
